News
Diagnostics company Guardant Health (NASDAQ:GH) will be reporting earnings tomorrow after market hours. Here’s what you need ...
Analysts expect the New York-based company to report quarterly earnings at 68 cents per share, down from 82 cents per share ...
Hosted on MSN8d
3 Reasons to Sell GH and 1 Stock to Buy InsteadWhat a time it’s been for Guardant Health. In the past six months alone, the company’s stock price has increased by a massive ...
Guardant Health, Inc. (NASDAQ:GH) on Thursday announced a strategic collaboration with Pfizer, Inc. (NYSE:PFE) to support the ...
Aristotle Atlantic Partners, LLC, an investment advisor, released its “Core Equity Strategy” first quarter 2025 investor ...
Precision oncology company Guardant Health has announced a strategic collaboration with Pfizer to support the development and ...
Guardant Health (GH) announced a strategic collaboration with Pfizer (PFE) to support the development and commercialization of Pfizer’s ...
Guardant Health Inc. advanced stock charts by Barron's. View GH historical stock data and compare to other stocks, and exchanges.
PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced a strategic collaboration with Pfizer, Inc. (NYSE: PFE), to support ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results